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As with all orally consumed probiotics, the Gram-positive bacterium Lactobacillus
reuteri encounters numerous challenges as it transits through the gastrointestinal tract
of the host, including low pH, effectors of the host immune system, as well as
competition with commensal and pathogenic bacteria, all of which can greatly reduce
the availability of live bacteria for therapeutic purposes. Recently we showed that
L. reuteri, when adhered in the form of a biofilm to a semi-permeable biocompatible
dextranomer microsphere, reduces the incidence of necrotizing enterocolitis by 50%
in a well-defined animal model following delivery of a single prophylactic dose. Herein,
using the same semi-permeable microspheres, we showed that providing compounds
beneficial to L. reuteri as diffusible cargo within the microsphere lumen resulted in further
advantageous effects including glucosyltransferase-dependent bacterial adherence to
the microsphere surface, resistance of bound bacteria against acidic conditions,
enhanced adherence of L. reuteri to human intestinal epithelial cells in vitro, and facilitated
production of the antimicrobial compound reuterin and the anti-inflammatory molecule
histamine. These data support continued development of this novel probiotic formulation
as an adaptable and effective means for targeted delivery of cargo beneficial to the
probiotic bacterium.
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INTRODUCTION
Probiotic bacteria are “live microorganisms that, when administered in adequate amounts, confer
a health benefit on the host” (Araya et al., 2006). Commercially, probiotics can be diverse genera
of bacteria both alone and in combination are utilized for the treatment of numerous ailments
and diseases, such as diarrheal diseases (McFarland, 2006; Johnston et al., 2012), infant colic
(Savino et al., 2010; Sung et al., 2014), allergies (Soh et al., 2009; Stefka et al., 2014), and elevated
LDL-cholesterol (Agerholm-Larsen et al., 2000; Nguyen et al., 2007).
Orally consumed beneficial bacteria face a gauntlet of challenges in the host, such as low pH in
the stomach, effectors of the host immune system and competition with commensal and pathogenic
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bacteria (Ding and Shah, 2007). All of these factors negatively
impact the ability of ingested probiotic bacteria to be sufficiently
sustained within the host and thus reduce the potentially
beneficial effects conferred. Commercially, encapsulation of
lyophilized probiotics is used as the primary means to protect
bacterial viability (Cook et al., 2012; Kailasapathy, 2014), however
there is no evidence of improved probiotic persistence within the
host.
We have devised a novel delivery method that utilizes hollow
semi-permeable, biocompatible and biodegradable microspheres
comprised of cross-linked dextran (dextranomer microspheres
or DMs). We have previously shown that allowing the probiotic
bacterium Lactobacillus reuteri to adhere to DMs prior to
oral delivery reduces the incidence of experimental necrotizing
enterocolitis (NEC) (a disease of high mortality in premature
infants born under 1,500 g, Neu and Walker, 2011) by 50%
with a single dose in a rat model of the disease (Olson et al.,
2016). Importantly, in the same study, a single dose of planktonic
L. reuteri showed no prophylactic effect. We surmised that it
was delivery of the probiotic bacteria in the biofilm state that
facilitated the significantly increased therapeutic value of L.
reuteri in this model system. According to our model (as shown
in Figure 1), bacteria on the surface of the DMs in the form of
a biofilm (i.e., an adhered community of bacteria that produces
a self-forming protective matrix to resist adverse environmental
conditions, Hall-Stoodley et al., 2004), would also have ready
access to any beneficial compounds that diffused from the lumen
of the DMs.
The choice to pair the Gram-positive bacterium L. reuteri
with DMs is many fold. L. reuteri is a popular choice for
commercialization due to its production of lactic acid and
the antimicrobial compound reuterin, a metabolite of glycerol
metabolism known chemically as 3-hydroxypropionaldehyde
(3-HPA), which typically exists in equilibrium with other
downstream products such as 3-HPA hydrate and acrolein
(Talarico et al., 1988; Engels et al., 2016). Reuterin induces
oxidative stress in a broad range of microorganisms (Schaefer
et al., 2010), and is highly effective at inhibiting growth of many
gastrointestinal pathogens (el-Ziney and Debevere, 1998; Arques
et al., 2004; Spinler et al., 2008; De Weirdt et al., 2012). In
addition to the antimicrobial reuterin, L. reuteri also produces
anti-inflammatory factors including histamine that modulate
cytokine production in vitro (Jones and Versalovic, 2009) and
ameliorate the symptoms of inflammatory bowel disease (Ghouri
et al., 2014). Indeed, in animal models, L. reuteri can prevent
the exacerbating effects of the physiological stress response
on colonic inflammation. However, once administration of L.
reuteri is terminated, colonic inflammation is again exacerbated
(Mackos et al., 2016). Thus, strategies to enhance the ability of L.
reuteri to better persist in the GI tract may have more impactful
therapeutic value.
Integral to our probiotic formulation strategy is L. reuteri’s
extracellular glucosyltransferase (GTF) protein, which in the
strain of L. reuteri used in this study (DSM 20016, containing
GTFW encoded by gtfW) (Leemhuis et al., 2013; Bai et al.,
2015) catalyzes the formation of exopolysaccharides of glucose
(glucans) from its sole known substrate maltose. Importantly,
FIGURE 1 | Model of novel probiotic delivery formulation. (A) A biofilm of
L. reuteri (green) adhered to the surface of a dextranomer microsphere (gray)
that contained beneficial compounds as cargo (purple and pink spheres) within
the lumen of the microsphere. (B) Over time, the cargo will diffuse out of the
porous microsphere thereby facilitating ready access by the adhered bacteria.
GTF proteins typically have a glucan binding domain that
recognizes its own produced exopolysaccharide (Monchois et al.,
1999; Kralj et al., 2004). The GTF protein, its substrate, and
resulting glucan product are highly strain-specific in L. reuteri;
some are characterized as producing dextran (primarily α-1,6
linkages), mutan (primarily α-1,3 linkages), or the aptly named
reuteran (primarily α-1,4 linkages) (Kralj et al., 2002, 2004). Cell
aggregation, biofilm formation, and gut colonization are directly
linked to the activity of GTFA in L. reuteri strain TMW1.106;
inactivating gtfA significantly diminishes the ability of L. reuteri
to aggregate, form biofilms, and colonize the GI tract in vivo
(Walter et al., 2008).
Our novel approach was to choose DMs (a macroscopic
porous microsphere that is sold commercially for size exclusion
chromatography, Porath and Flodin, 1959) as a biocompatible
surface so as to take advantage of L. reuteri’s GTFW native
ability to bind to this cross-linked dextran (Tieking et al., 2005;
Schwab et al., 2007; Walter et al., 2008). Our strategy is based on
concurrent research which shows that the highly similar GTFs
of Streptococccus mutans, an oral pathogen that contributes to
tooth decay, binds to DMs with high affinity (Mooser et al., 1985)
and, as a consequence of GTF being cell-associated, results in
strong binding of S. mutans to DMs (Mashburn-Warren et al.,
submitted). Here in we show that GTFW-dependent binding of
L. reuteri to DMs results in: one, selectivity of binding to DMs
and as a result better binding of L. reuteri to colonic epithelial
cells; two, protection against low pH and three, the ability of L.
reuteri to acquire the luminal contents of the DMs at sufficiently
high concentrations to enhance L. reuteri’s probiotic effects.
MATERIALS AND METHODS
Strains and Culturing Conditions
Bacterial strains, plasmids and oligonucleotides used are listed in
Table 1. L. reuteri (ATCC 23272) and Lactobacillus rhamnosus
GG (ATCC 53103) were grown inMRS (deMan, Rogosa, Sharpe)
medium (De Man et al., 1960) (BD, Franklin Lakes, NJ) for
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TABLE 1 | Bacterial strains, cell lines, plasmids, and oligos used in this study.
Bacterial strains Description Source/Reference
Lactobacillus reuteri Wild type (GTFW) American Type
ATCC 23272 Culture Collection
LMW500 L. reuteri 23272 1gtfW; CmR This study
LMW501 L. reuteri 23272 + pWAR501 CmR This study
LMW502 E. coli ER2566 + pWAR502 This study
LMW503 L. reuteri 23272 + pWAR503 CmR This study
Lactobacillus rhamnosus Wild type (non-dextran forming GTF) G. Rajashekara
GG ATCC 53102 J.S. Gunn
Salmonella enterica Wild type (non-dextran forming GTF)
serovar typhi TY2ATCC
700931
Citrobacter rodentium Wild type (non-dextran forming GTF) American Type
ATCC 51459 Culture Collection
Clostridium difficile Wild type (non-dextran forming GTF) J.K. Spinier
R20291 (BI/NAP1/027)
Human cell lines Description Source/Reference
DLD-1 ATCC CCL-221 Human colonic epithelial cells (colorectal adenocarcinoma) G.E. Besner
FHs 74 Int ATCC CCL-241 Human fetal small intestinal epithelial cells G.E. Besner
Plasmids Description Source/Reference
pWAR500 pFED760 (Mashburn-Warren et al., 2012) derivative containing cat and DNA fragments
flanking gtfW to create insertion mutant; see Materials and Methods; CmR, ErmR
This study
pWAR501 pJC156 (Mashburn-Warren et al., 2012) derivative containing the promoter region of gtfW
upstream of the click beetle luciferase; see Materials and Methods; CmR
This study
pWAR502 pTXB1 derivative containing gtfW (with its stop codon); see Materials and Methods; AmpR
pWAR503 pJC156 (Mashburn-Warren et al., 2012) derivative containing the promoter region of
elongation factor Tu (EF-Tu) upstream of the click beetle luciferase; see Materials and
Methods; CmR
This study
Oligos DNA sequence* Source/Reference
oSG1082 GCGTGGCGGCCGCCATTATTTTCATGTAGTGTATT T This study
oSG1083 GCGTGGTCGACCTTTTTTATGTCCATAATCTATT This study
oSG1084 GCGTGGTCGACGAAAATATTTAATATGAAAATGA This study
oSG1085 GCGTGCTCGAGCCAAGCACTATTTCACGAGAAT This study
LMW34 GCGTGGTCGACGATGAAAATTTGTTTGATTT Mashburn-Warren et al., 2012
LMW35 GCGTGGTCGACTTATAAAAGCCAGTCATTAG Mashburn-Warren et al., 2012
oSG1102 GCGTGCTCGAGCAACAAGAGTATCAGGGTAAAGC This study
oSG1103 GCGTGGTCGACTCCTTCCCAATAGATGATTGATT This study
oSG1067 GCGTGGTCGACATGGTAAAACGTGAAAAAAATGT This study
oSG1068 GCGGCCGCTCCGCCAGCTTTTTCTAATAACT This study
oSG1120 GCGTGGCTAGCATGAACCTGCCAACAATTCCTAA This study
oSG1126 GCGTGGCTCTTCCGCATTAAATATTTTCTTGGTTT This study
oSG1069 GCGTGCTCGAGCGCAACAAATACAGTTTCTAATA This study
oSG1070 GCGTGGTCGACAAACCTCCTGATAATTTACAAGT This study
CmR, chloramphenicol resistant; ErmR, Erythromycin resistant; AmpR, Ampicillin resistant.
*Sequences in bold indicate restriction enzyme sequences.
16 h at 37◦C, 5% CO2. Salmonella typhi (strain JSG698) and
Citrobacter rodentium (ATCC 51459) were grown in Lysogeny
broth (LB) at 37◦C, 5% CO2. Clostridium difficile (strain R20291)
was grown in degassed brain-heart infusion (BHI) medium
(BD, Franklin Lakes, NJ) at 37◦C in an anaerobic chamber
(Thermo Forma Scientific, 1025 Anaerobic System, Hampton,
NJ) established with an atmosphere of 5% H2, 85% N2, and
10% CO2. DLD-1 (ATCC CCL-221) human colonic cells were
grown in RPMI medium supplemented with 10% fetal bovine
serum at 37◦C, 5% CO2. FHs 74 Int (ATCC CCL-241) human
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fetal small intestinal cells were grown in Hybri-Care medium
(ATCC 46-X) supplemented with 30 ng/ml epidermal growth
factor (EGF) and 10% fetal bovine serum at 37◦C, 5% CO2. The
gtfW deletion strain (LMW500) was constructed by insertion
of a chloramphenicol resistance cassette (cat) into the gtfW
open reading frame by allelic exchange as described previously
(Mashburn-Warren et al., 2012). Briefly, 1kb fragments upstream
and downstream of gtfW were amplified by PCR using oligos
oSG1082-1083 and oSG1084-1085, followed by cloning into
pFED760 (Mashburn-Warren et al., 2012) using NotI/SalI
and SalI/XhoI restriction sites, respectively. The cat cassette
was amplified from pEVP3 (Mashburn-Warren et al., 2012)
using oligos LMW34-35, followed by cloning into pFED760
that contained the upstream and downstream fragments of
gtfW using the SalI restriction site. The resulting gtfW
knock-out construct plasmid (pWAR500) was then introduced
into L. reuteri ATCC 23272 by electroporation. L. reuteri
electrocompetent cells were prepared by growing 5 ml of culture
in MRS at 37◦C with 5% CO2 until OD600nm of ∼1.0. Cells were
then pelleted and resuspended in 10 ml of sterile cold 0.5 M
sucrose and 10% glycerol twice, followed by a final resuspension
in100 µl sterile cold 0.5 M sucrose and 10% glycerol. To this
resuspension 1 µg of pWAR500 was added and the cell/DNA
mixture was placed into an ice cold 2 mm electroporation
cuvette (BioRad, Hercules, CA). Cells were electroporated at
2500V, 25 µF and 400  using a BioRad Gene Pulser Xcell
(BioRad, Hercules, CA). Immediately after electroporation, cells
were resuspended in 1 mL of MRS and incubated at 30◦C for 2 h,
followed by serial dilution and plating onto MRS agar containing
5 µg/ml chloramphenicol and incubated at 30◦C. The mutant
was selected and confirmed as previously described (Chang et al.,
2011).
To estimate transcription from the gtfW promoter (PgtfW),
the PgtfW-CBluc reporter plasmid was constructed by amplifying
the promoter region 350 bp upstream of the gtfW start codon
(including the native ribosome binding site) by PCR using oligos
oSG1102-1103. The resulting DNA fragment was inserted into
pJC156 using the XhoI/SalI restriction sites. The click beetle
luciferase (CBluc) gene was amplified from the Streptococcus
mutans strain ldhCBGSm (Merritt et al., 2016) using oligos
oSG1067-1068 and inserted downstream of the gtfW promoter
region in pJC156 using SalI/NotI restriction sites. The resulting
reporter plasmid pWAR501 was transformed into L. reuteri
23272 as described above to create the reporter strain LMW501.
The E. coli gtfW overexpression strain (LMW 502) was
created by amplifying the L. reuteri gtfW open reading frame
(including the stop codon) using primers oSG1120-1126. The
resulting DNA fragment was inserted into pTXB1 (New England
BioLabs, Ipswich, MA) using NheI/SapI restriction sites. The
resulting plasmid, pWAR502 was then transformed into the E.
coli expression strain ER2566 (New England BioLabs, Ipswich,
MA) and selected on LB agar containing 100 µg/ml ampicillin
and confirmed by DNA sequencing. This strain allows the
overexpression of tagless GTFW protein.
To produce a L. reuteri strain constitutively expressing
click beetle luciferase, a reporter plasmid was constructed
by amplifying the promoter region 250 bp upstream of the
elongation factor Tu (EF-Tu) start codon (including the native
ribosome binding site) by PCR using oligos oSG1069-1070. The
resulting DNA fragment was inserted into pJC156 using the
XhoI/SalI restriction sites. The click beetle luciferase (CBluc)
gene was amplified from the S. mutans strain ldhCBGSm (Merritt
et al., 2016) using oligos oSG1067-1068 and inserted downstream
of the EF-Tu promoter region in pJC156 using SalI/NotI
restriction sites. The resulting reporter plasmid pWAR503 was
transformed into L. reuteri 23272 as described above to create
LMW503.
Microsphere Preparation and Application
Anhydrous dextranomer microspheres (DMs; Sephadex R© G-25
Superfine) were purchased from GE Healthcare Life Sciences
(Pittsburgh, PA). Anhydrous cellulose microspheres (CMs;
Cellulobeads D50) were obtained from Kobo Products, Inc.
(South Plainfield, NJ). Anhydrous microspheres were hydrated
in growth medium or water at 50 mg/ml then autoclaved for 20
min. For conditions with microspheres that contained maltose,
sucrose, fructose, or glucose only, microspheres previously
autoclaved in water were removed from solution on a vacuum
filter apparatus and approximately 50mg were collected via
sterile loop into 1ml of filter-sterilized 1M solution of the sugar
(see Figure S1). The microsphere mixture was then vortexed
vigorously and incubated for 24 h at room temperature to reach
equilibrium.
For application with L. reuteri, microspheres loaded with
water, 1M maltose, 1M sucrose, 1M glucose, or 1M fructose
were removed from solution on a vacuum filter apparatus and
collected via a 10µl sterile loop. Approximately 5mg of hydrated
microspheres were then added to 1 ml of 2 × 109 CFU L. reuteri
from an overnight culture that had previously been pelleted
by centrifugation at 3220 × g for 10 min, washed twice with
sterile 0.9% saline, and resuspended in 1 ml sterile saline. For
experiments involving eukaryotic cell lines, 2 × 109 CFU of
bacteria were resuspended in 1 ml RPMI instead of saline. For
experiments with no microspheres but equivalent volume of
cargo, 10µl of cargo was added to 1 ml of bacteria either in sterile
saline or RPMI. For all experiments, the bacteria andmicrosphere
mixture were incubated together at room temperature for 30
min (unless otherwise stated) to facilitate bacterial adherence and
biofilm formation on the microsphere surface prior to use in
assays.
Microsphere Adherence Assay
L. reuteri culture was grown and prepared as described above
and incubated with microspheres filled with either: water, 1M
maltose, 1M sucrose, 1M fructose, or 1M glucose. To examine
bacterial adherence to the microspheres, 300 µl of bacteria (from
an overnight culture containing ∼2 × 109 CFU) in sterile saline
and 5mg of microspheres were combined and incubated for 5
min in a Micro Bio-Spin column (BioRad, Hercules, CA) (see
Figure S2). The columns were then centrifuged (100 × g) for 1
min. The flow-through was serially diluted and plated to calculate
the total number of non-adhered bacteria, and this value was
subtracted from the total number of starting bacteria to derive the
total number of adhered bacteria. For all experiments, a control
Frontiers in Microbiology | www.frontiersin.org 4 March 2017 | Volume 8 | Article 489
Navarro et al. Enhanced Probiotic Potential of L. reuteri
preparation that consisted of bacteria with no microspheres was
used.
Reporter Assay
The reporter strain LMW501 was grown at 37◦C with 5%
CO2in MRS or MRS containing 3% glucose, sucrose, fructose,
or maltose and optical densities (OD600nm) of the cultures
were measured throughout growth using an Epoch Microplate
Spectrophotometer (BioTek Instruments Inc., Winooski, VT).
At the indicated times, 80 µl aliquots of the bacterial cultures
were mixed with 20 µl 2 mM D-luciferin in 0.1M citrate buffer,
pH 6.0 and placed in a Falcon white flat-bottom 96-well plate
(Becton, Dickinson Labware, Franklin Lakes, NJ), followed by
luminescence detection using a Veritas Microplate Luminometer
(Turner BioSystems Inc., Sunnyvale, CA).
GTF Enzymatic Assay
S. mutans was grown in Todd Hewitt Broth at 37◦C with 5%
CO2 until early log phase (OD600nm ∼0.3), L. reuteri WT and
the 1gtfW mutant were grown in MRS at 37◦C with 5% CO2
until late log phase (OD600 nm ∼1.0) for optimal gtf expression,
and the E. coli gtfW overexpression strain was grown in LB
broth at 37◦C shaking (200 rpm) until mid-log phase (OD600 nm
∼0.4) followed by the addition of 1 mM IPTG to induce gtfW
expression and was then grown at 37◦C shaking for an additional
2 h. Whole cells of S. mutans, L. reuteri WT, L. reuteri 1gtfW,
and the E. coli gtfW overexpression strain were assayed for GTF
activity as previously described (Bai et al., 2015) using Periodic
acid-Schiff staining of SDS-PAGE gels.
Cargo Diffusion Assay
The rate of cargo diffusion out of the microspheres was
determined by tracking crystal violet, a small molecular weight
dye (407.979 g/mol) (Fisher Scientific, Hampton, NJ). The
microspheres were loaded with a 0.1% solution of crystal violet
by incubating 20mg of microspheres in 1ml of 0.1% crystal
violet solution either with or without added glycerol (40 or
80% v/v) overnight to reduce the diffusion rate by increasing
viscosity. After 16 h, excess crystal violet solution was removed
from the microspheres as described above using a vacuum filter
apparatus. The crystal violet-loaded microspheres were then
placed into 1 ml of water, and aliquots of water were removed
and analyzed for diffusion of crystal violet into solution using
an Epoch Microplate Spectrophotometer (BioTek, Winooski,
VT) at OD590nm every hour for 16 h. Percent diffusion was
calculated using the equivalent amount of crystal violet within
the microspheres (10 µl) in water as a control equivalent to 100%
cargo diffusion.
Reuterin Assay
Production of reuterin by L. reuteri was measured via a
quantitative colorimetric assay (Cadieux et al., 2008). As this
assay did not differentiate between similar aldehyde products,
measurements included 3-HPA and any potential derivatives,
such as acrolein and 3-HPA hydrate. L. reuteri was grown
overnight in MRS as described above, 1 ml aliquots of 2 × 109
CFU were pelleted at 3,220 × g for 10 min, washed twice with
sterile saline, and resuspended in either 1 ml of sterile saline or
1 ml sterile saline containing 2% v/v glycerol. DM containing 0,
2, 10, 20, 30, 40, 50, 60, 70, or 80% glycerol were prepared as
described above for other cargo, and added to the resuspended
L. reuteri in saline (so that the only source of glycerol available
for reuterin production was via the microsphere cargo) for 1
h at 37◦C. Cells were then pelleted again and the reuterin-
containing supernatant was removed, filtered through a 0.45 µm
filter, and assayed for reuterin as described in Cadieux et al.
(2008) without modification. A standard curve using reuterin
at known concentrations was used to extrapolate bacterial-
produced reuterin concentrations from DM-glycerol and the 2%
v/v glycerol control experimental conditions.
L. reuteri Survival with DM-80% Glycerol
Overnight cultures of WT L. reuteri were aliquoted into
microcentrifuge tubes, centrifuged, washed twice with sterile
saline, and resuspended in either 1 ml saline or 1 ml MRS
medium. Five mg of either DM-water or DM-80% glycerol were
then added to the tubes and incubated at 37◦C. At hourly
intervals the tubes were mixed thoroughly and aliquots were
taken for subsequent serial dilution and plating for viable CFU
of bacteria.
Histamine Assay
Production of histamine from L-histidine by L. reuteri was
measured via ELISA (Enzo Life Sciences, Inc., Farmingdale, NY).
L. reuteri was grown overnight in MRS as described above,
1 ml aliquots of 2 × 109 CFU were pelleted at 3220 × g for
10 min, washed twice with sterile saline, and resuspended in
one of the following conditions: sterile saline, saline with 3%
maltose, saline with 2% v/v glycerol, 4mg/ml L-histidine (Sigma-
Aldrich, St. Louis, MO), 4mg/ml L-histidine with 3% maltose, or
4 mg/ml L-histidine with 2% v/v glycerol. 5mg of DM containing
either 4mg/ml or 30 mg/ml L-histidine were added to media
lacking L-histidine, so that the only source of L-histidine for L.
reuteri was as cargo diffusing out of the DMs. Each condition
was then incubated at 37◦C for 2 h, after which time the contents
were pelleted and the supernatant was removed for histamine
quantification via a histamine ELISA kit (Enzo Life Sciences,
Inc., Farmingdale, NY) following the manufacturer’s instructions
without modifications. All conditions were done in at least
triplicate.
pH Survivability Assay
Bacteria were exposed to a synthetic gastric acid equivalent to
determine survival at pH 2. Gastric acid equivalent is a modified
version of synthetic gastric fluid (Cotter et al., 2001), composed
of 0.1M HCl, 0.1M NaCl, and 0.01M KCl, with pH adjusted to
2 using 0.1M NaOH. For the assay, 1 ml of 2 × 109 CFU of L.
reuteri from a fresh overnight culture were pelleted at 3,220 ×
g for 10 min, washed twice with sterile saline, and resuspended
in 1 ml 0.9% sterile saline. The cells were incubated for 30 min
with approximately 5mg of loaded or unloaded microspheres
as described above, and the bacteria-microsphere mixture was
diluted 1:100 directly into gastric acid equivalent. Aliquots of the
inoculated acid solution were mixed, serially diluted, and plated
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at hourly time points for 4 h to determine the number of viable
bacteria. Bacteria without microspheres were used as a control.
Adherence to Intestinal Epithelial Cells
DLD-1 colonic cells and FHs 74 small intestinal cells were
cultured as described above. When the adherent epithelial cells
reached confluence, the growth medium was removed, cells were
washed twice with sterile phosphate buffered saline (PBS), and
trypsin-EDTA (0.25%) was added for 10 min at 37◦C to dislodge
the cells from the culture flask surface. Total epithelial cells were
counted using a hemacytometer (Hausser Scientific, Horsham,
PA). Cells were then diluted to a concentration of 5 × 105
cells/ml and 1 ml per well was seeded into a 24-well plate and
incubated at 37◦C, 5% CO2. After either 48 h (for DLD-1 cells)
or 120 h (for FHs 74 cells) of growth, the spent medium was
removed and replaced with 1 ml of RPMI or Hybri-Care medium
containing 2 × 109 CFU of L. reuteri alone, L. reuteri with 5mg
water-filled DMs, L. reuteri with 5mg sucrose-filled DMs, or L.
reuteri with 5mg maltose-filled DMs. After a 1 h incubation,
the spent medium was removed and the well was washed with
1 ml of sterile PBS 3 times to remove non-adhered bacteria.
The remaining epithelial cells, with adhered bacteria, were then
trypsinized as described above, serially diluted, and plated onto
solidMRSmedium for enumeration of total adhered bacteria. For
confocal microscopy experiments with DLD-1, Nunc Lab-Tek
8-well borosilicate chamber slides (Fisher Scientific, Hampton,
NJ) were used in place of 24-well plates. The chamber slides
were treated with collagen prior to DLD-1 seeding to improve
cellular adherence using the following protocol: a mixture of 100
µl of 7.5% BSA (Sigma-Aldrich, St. Louis, MO), 50 µl of 3.79
mg/ml collagen (Millipore, Temecula, CA), 100µl of 1 mg/ml rat
fibronectin (Biomedical Technologies, Stoughton, MA), and 9.75
ml of PBS was prepared, and 200µl of this solution was added per
chamber slide well. After incubation for 1 h at 37◦C, the solution
was removed from the well, and epithelial cells were seeded and
grown as described above.
Mucin Adherence Assay
Mucin agar plates were created using porcine stomach mucin
(Sigma-Aldrich, St. Louis, MO). Mucin agar plates contained
2% mucin and 0.8% agar to simulate the consistency of the
mucus layer found in vivo (Macfarlane et al., 2005; Van den
Abbeele et al., 2009). To assess L. reuteri’s ability to bind mucin,
2 × 109 CFU of L. reuteri that contained a plasmid that
encoded expression of the click beetle luciferase enzyme either
planktonically or bound to 5mg DM-water, DM-sucrose, or DM-
maltose were incubated on both mucin agar and agar without
mucin stationary at room temperature. After 60min, the non-
adhered L. reuteriwere removed by washing the plates twice with
sterile saline. The luciferase substrate D-luciferin (Sigma-Aldrich,
St. Louis, MO) was then added to the plates at a concentration
of 0.4 mM to visualize the remaining adhered bacteria. Relative
luminosity generated from the bacteria on the plates was
measured using a FluorChem E system (ProteinSimple, San Jose,
CA) with a 20min exposure setting. To assess the number of
bacteria bound to the mucin within the plate (and not any
background binding that may occur to the agar within the plate),
the amount of luminescent signal from the agar-only plates was
subtracted from the mucin agar plates.
Confocal Microscopy
All confocal laser scanning microscopy (CLSM) was performed
using a Zeiss LSM 510 confocal microscope (Ziess AG,
Oberkochen, Germany). For fluorescent staining, dextranomer
and cellulose microspheres were pre-stained with Congo Red
(Fisher Scientific, Hampton, NJ) prior to incubation with the
cargo (e.g., sucrose) and experiments with bacteria. L. reuteri
was stained with SYTO 9 (Life Technologies, Carlsbad, CA).
Differential fluorescent visualization was performed using the
following settings: Congo Red excitation 554 nm/emission 568
nm, and SYTO 9 excitation 490 nm/emission 525 nm. Samples
were fixed using a custom biofilm fixative containing 1.5%
paraformaldehyde, 0.025% glutaraldehyde, 4.0% acetic acid, and
0.1M phosphate buffer at pH 7.4 (Devaraj et al., 2015). All
microscopy was performed on samples in Nunc Lab-Tek 8-
well borosilicate chamber slides (Fisher Scientific, Hampton,
NJ). For CLSM experiments with DLD-1 epithelial cells, DLD-
1 was stained with 4′,6-Diamidino-2-Phenylindole (DAPI, Life
Technologies, Carlsbad, CA), L. reuteri was stained with
carboxyfluorescein succinimidyl ester (CFSE, Life Technologies,
Carlsbad, CA). AxioVision software (Ziess AG, Oberkochen,
Germany) and ICY (de Chaumont et al., 2012) were used to
analyze images and create figures fromCLSM images. COMSTAT
(Heydorn et al., 2000) software was used to quantify bacterial
biomass in CLSM images.
For in vitro biofilm assays, overnight cultures of WT and
1gtfW L. reuteri were diluted into fresh MRS growth medium
to 0.01 OD600nm, incubated at 37
◦C 5% CO2 for 2.5 h until
reaching 0.65 OD600 nm, diluted 1:2,500 into either MRS, MRS
+ 3% sucrose, or MRS + 3% maltose, seeded into 8-well
borosilicate chamber slides and incubated for 1, 3, or 6 h at
37◦C 5% CO2. At the designated time intervals, the bacteria were
stained for viability with LIVE/DEAD stain, fixed, visualized via
confocal microscopy, and quantified via COMSTAT analysis of
the fluorescent signal.
Scanning Electron Microscopy
All scanning electron microscopy (SEM) was performed using
a Hitachi S-4800 field emission SEM (Hitachi, Tokyo, Japan).
Samples were prepared as described in “Adherence to colonic
cells,” with the exception that DLD-1 human colonic epithelial
cells were grown on 15mm diameter thermanox coverslips
(Electron Microscopy Sciences, Hatfield, PA) placed within the
well of a 12-well plate. Samples of DLD-1 cells and adhered
bacteria were fixed overnight at 4◦C in a solution of 2.5%
glutaraldehyde in 0.1M phosphate buffer (pH 7.2). Samples were
then washed with double distilled water and stained with a 1%
solution of osmium tetroxide (Sigma-Aldrich, St. Louis, MO) in
0.1M phosphate buffer (pH 7.2) for 1 h, washed for 5min, stained
with a 1% solution of thiocarbohydrazide (Sigma-Aldrich, St.
Louis, MO), washed for 5min, and further stained with 1%
osmium tetroxide for 30min. Samples were then dehydrated
using a graded series of ethanol: 25% ethanol for 15 min,
50% ethanol for 15min, 70% ethanol for 30min, 95% ethanol
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for 15 min (twice), 100% ethanol (twice), a 1:1 mixture of
100% ethanol to 100% hexamethyldisilazane (HMDS, Sigma-
Aldrich, St. Louis, MO) for 100 min, 100% HMDS for 15
min, and a final immersion in 100% HMDS that was allowed
to air dry overnight. Dehydrated sample coverslips were then
mounted onto 15 mm diameter metal SEM specimen stubs
(Electron Microscopy Sciences, Hatfield, PA) using colloidal
silver (Electron Microscopy Sciences, Hatfield, PA). The outer
edge, where the stub and coverslip meet, was then coated with
a light layer of colloidal silver, and allowed to dry overnight.
Samples were sputter coated with gold and palladium for 2 min
at 25 mA using an Emitech K550X sputter coater (Quorum
Technologies Ltd., Laughton, United Kingdom).
Statistical Analysis
All experiments were conducted a minimum of three times and
statistical analysis was performed via a Student’s t-test using
GraphPad Prism software (GraphPad Software, Inc., La Jolla,
CA), wherein a P-value less than 0.05 was accepted as significant.
RESULTS
Maltose or Sucrose within the Lumen of
DMs Improved L. reuteri Adherence to
DMs in a GTF-Dependent Manner
Our strategy was to have probiotic bacteria adhere to a
biocompatible surface to induce the formation of a biofilm
(Figure 1). To investigate this, we differentially stained DMs with
Congo Red and L. reuteri with SYTO 9, and examined binding
via confocal laser scanning microscopy (CLSM). As shown in
Figure 2, aggregates of bacteria were associated with the surface
of numerous DMs which indicated that L. reuteri was able to
adhere to the DM surface within the time allotted. Since DMs are
cross-linked glucan similar to the native reuteran produced by
L. reuteri, we hypothesized that either an increase in GTFW (for
enhanced binding to DMs) or production of glucan to stimulate
aggregation and biofilm formation would facilitate the adhered
state of L. reuteri. To this end, we compared adherence of L.
reuteri to DMs that contained luminal cargo of either sucrose (an
FIGURE 2 | L. reuteri binds to dextranomer microspheres. Confocal laser
scanning microscopy (CLSM) of L. reuteri adhered to DMs. (A) Water-filled
DMs, (B) sucrose-filled DMs, and (C) maltose-filled DMs after incubation with
L. reuteri for 30 min showed that L. reuteri adherence to DMs can be
enhanced to incorporate biofilm-promoting cargo within the DM lumen (green:
bacteria stained with SYTO 9, red: DMs stained with Congo Red).
inducer of gtfW expression but not a substrate for GTFW; see
Figure S3) or maltose (the sole substrate of GTFW). As shown
in Figures 2B,C, compared to DMs that contained only water
within the lumen (Figure 2A) there were greater numbers of L.
reuteri adhered to DMs with either sugar as cargo.
To further investigate L. reuteri’s ability to bind DMs, we
tested other DM lumen compounds that we hypothesized should
not affect GTFW protein mediated binding and thus unlikely to
support increased adherence to DMs. For this assay we chose the
monosaccharide subunits of maltose and sucrose (e.g., glucose
for maltose, glucose and fructose for sucrose), which the GTF
enzyme cannot utilize to catalyze glucan polymers. Interestingly,
fructose (and not glucose) was shown to induce gtfW expression
at a rate similar to sucrose, but did not result in enhanced binding
to DMs as was found with sucrose (Figure S3A, Figure 3A).
To determine if this GTFW-dependent binding is specific to
the glycosyl linkages of DMs, we compared L. reuteri binding to
cellulose microspheres (CMs), as DMs are composed of polymers
of glucose with α-linkages while CMs possess β-linkages between
the glucose units (Updegraff, 1969; Kralj et al., 2002). As shown in
Figure 3A, only∼10% of L. reuteri adhered to CMs regardless of
luminal contents. Collectively the data in Figure 3 indicated that
L. reuteri does not bind to CMs, binding to DMs was GTFW-
dependent and further, that inclusion of maltose or sucrose
significantly enhanced the binding of L reuteri to DMs. We
hypothesized that the predicted glucan binding domain of GTFW
is a necessary component of L. reuteri’s ability to adhere to
DMs. To further test if the adherence to DM is GTF-dependent,
we created a mutant strain of L. reuteri (LMW500) with a
chloramphenicol resistance gene inserted in place of the gtfW
gene. As shown in Figure 3B, the 1gtfW strain was not able to
bind to DMs as effectively as the wild type (WT) in our spin
column assay, regardless of the cargo within the DM lumen. To
further demonstrate the difference between the WT and 1gtfW,
we examined biofilm formation on glass chamber slides in media
supplemented with sucrose or maltose (Figure S4). After a 1 h
incubation, the WT had more bacteria present and noticeably
more bacterial aggregation when sucrose or maltose was added
to the growth medium (Figures S4A,B). After 3 and 6 h with
sucrose or maltose supplemented media, the WT displayed a
significantly more robust biofilm with greater biomass compared
to the gtfW mutant under every condition, with significantly
more cells present when sucrose or maltose was in the growth
medium (Figures S4A,C,D).
We next tested whether bacteria that do not express a
similar GTF would lack the adherent phenotype shown in
Figures 3A,B. To examine this, we performed our DM adherence
assay with another probiotic bacterium and three enteric
pathogens that L. reuteri would likely encounter within the
gastrointestinal tract: Lactobacillus rhamnosus GG, a Gram-
positive bacterium commonly found in the genitourinary system
and sold commercially as a probiotic; Salmonella typhi, a Gram-
negative bacterium responsible for typhoid fever in humans;
Citrobacter rodentium, a Gram-negative bacterium that causes
colitis in rodents; and Clostridium difficile, a Gram-positive
spore-forming bacterium that can cause severe colitis and
recurring infections in humans. As shown in Figure 3C, all of
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FIGURE 3 | Microsphere composition and lumen cargo affected L. reuteri adherence, L. reuteri adhered to DMs in GTFW-dependent manner, and
bacteria lacking GTF did not bind to DMs. A spin column assay was performed to assess relative bacterial adherence to microspheres. Bacteria were incubated
for 5 min with 5mg of microspheres, centrifuged at 100 × g to separate bound and unbound bacteria, then CFU of non-adhered bacteria were quantified in the
flow-through of the spin column. (A) Microspheres composed of either cross-linked dextran (DM) or cross-linked cellulose (CM) were filled with water or various sugars
at a concentration of 1M to determine which microsphere type supported greatest adherence of L. reuteri. (B) Relative WT and 1gtfW L. reuteri adherence to DM
showed that L. reuteri adhered to DMs in a GTF-dependent manner. (C) Non-GTF expressing bacteria were similarly tested for microsphere adherence with
water-loaded and sucrose-loaded DMs. Error bars represent standard error of the mean. Statistical significance is indicated by the following: *P < 0.05, **P < 0.01,
***P < 0.0005.
the non-GTF expressing bacteria showed minimal adherence to
DMs, regardless of cargo present within the DM lumen.
Diffusion of Cargo from DMs
Initial binding of bacteria to DMs is a critical component of
our formulation, however equally important is the ability to co-
deliver beneficial luminal cargo needed by the adherent bacteria
during transit of DMs through the gastrointestinal tract. Targeted
delivery of maltose (or any other beneficial compound) via
diffusion out of the DMs directly to the probiotic bacterium over
time was a desired feature of our system (Figure 1). However,
since themethod of cargo delivery would be diffusion through the
porous surface of the microsphere and not its degradation, such
as occurs in poly(lactic-co-glycolic) acid (PLGA) microspheres
(Danhier et al., 2012), the rate of diffusion is dependent upon the
size of the microsphere, the mass of the solute, and the viscosity
of the diluent. As proof of concept, we filled the DMs with crystal
violet, a small molecular weight stain (407.979 g/mol), and tested
the diffusion rate of the dye out of the DMs with and without
changing the viscosity of the solution in the DM lumen. As shown
in Figure 4, the crystal violet diffused out of the DM lumen with
a half-life of ∼6 h. When the viscosity was increased by adding
40% glycerol, the half-life of release was increased to∼8 h. At 80%
glycerol, the half-life of crystal violet release was further enhanced
to 12 h. By 16 h>95% of all of the crystal violet had been released
under all tested conditions.
L. reuteri Produced Reuterin From
Glycerol-Loaded Microspheres
An important feature of L. reuteri’s function as a probiotic
bacterium is its ability to compete with pathogenic bacteria
within the host potentially via production of antimicrobials e.g.,
extracellular reuterin (Cleusix et al., 2007; Spinler et al., 2008).
Due to limited glycerol availability, suboptimal endogenous
concentrations of glycerol in the GI tract would likely limit
adequate reuterin production. In order to obviate the need to
provide high levels of glycerol to satisfy L. reuteri’s optimal needs,
we provided targeted delivery of glycerol directly to the bacteria
attached to the surface of DMs. To test this in vitro, we utilized a
colorimetric assay for reuterin production (Cadieux et al., 2008).
As shown in Figure S5, DMs filled with glycerol concentrations
ranging from 10 to 80% were able to induce reuterin production.
Compared to the 2% glycerol solution control, DMs filled with
80% glycerol produced on average 53% more reuterin in 1 h
(average concentration of reuterin produced: 2% glycerol = 40
mM, DM-80% glycerol = 61 mM). To determine if the 80%
glycerol or the resulting reuterin/downstream metabolites of
glycerol fermentation produced by L. reuteri is toxic to L. reuteri,
we compared hourly colony forming units (CFU) of L. reuteri
incubated with either DM-water or DM-80% glycerol, in either
sterile saline or MRS growth medium. As shown in Figure S6,
there was no loss of CFU regardless of DM cargo when L. reuteri
was incubated in MRS. Incubating L. reuteri in saline did result
in a steady loss of viable CFU over time, though there was
no difference in viability between the DM-water and DM-80%
glycerol over this time, suggesting the loss of CFU was not due
to any potentially toxic compounds, such as reuterin or acrolein,
from glycerol fermentation (Figure S6). As acrolein in particular
is known to be toxic to humans and is a byproduct of reuterin
production, we next calculated the maximum possible amount
of acrolein that could be produced from the dosage of L. reuteri
and volume of glycerol provided via DMs in our formulation,
assuming all available glycerol was converted 1:1 into acrolein. As
shown in Figure S7, the amount of acrolein that could possibly be
produced via our formulation is a nominal∼6 µg (for reference,
the World Health Organization recommends less than 7.5 µg/kg
body weight per day) (Gomes et al., 2002). From these results and
the data presented in Figure 4, we hypothesized that DMs loaded
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FIGURE 4 | Diffusion of cargo out of microspheres over time. Crystal
violet (CV)-loaded DMs with and without glycerol (added to increase viscosity)
were assayed to determine the relative rate of CV diffusion from the
microspheres. With 0% added glycerol, CV diffused at a higher rate (100%
diffusion after 10 h) compared to DMs that contained 40 or 80% glycerol. We
observed 100% diffusion from DMs after 16 h regardless of viscosity. Error
bars represent standard error of the mean. Statistical significance from DMs
with 0% added glycerol is indicated by the following: *P < 0.05, **P < 0.01,
****P < 0.0001.
with glycerol would have two beneficial effects in vivo, namely
slowing the release of beneficial cargo and providing a substrate
for reuterin production.
L. reuteri Produced Histamine from
L-Histidine-Loaded Microspheres
Histamine produced by L. reuteri has previously been shown to
inhibit pro-inflammatory cytokines such as TNF via H2 receptors
and reduce colitis in an animal model (Thomas et al., 2012;
Gao et al., 2015). Our microsphere-based approach provides a
unique method for delivery of the histamine precursor substrate
L-histidine to L. reuteri. To test this in vitro, we filled DMs with
30 mg/ml and 4 mg/ml L-histidine and measured the amount
of histamine produced by the bacteria when the only source
of L-histidine was via diffusion out of the DMs. As shown
in Figure 5, DM- L-histidine (4mg/ml) resulted in histamine
levels only slightly lower than those produced when bacteria
were incubated in 4mg/ml L-histidine solution without DMs.
When the DMs were loaded with a higher concentration of
L-histidine, the amount of histamine produced was 6–7 times
greater than the lower 4mg/ml concentration, consistent with the
DM-L-histidine (30mg/ml) providing∼7 timesmore L-histidine
than the DM-L-histidine (4 mg/ml) (Figure 5). In addition,
we tested whether other cargo relevant DM cargo substrates,
such as maltose and glycerol, would negatively affect histamine
production. Addition of glycerol did not result in reduced
histamine production, regardless of whether the L-histidine was
in solution or provided via DMs (Figure 5). With addition
of maltose, histamine production actually increased when L-
histidine was provided in solution, but statistically unchanged
when L-histidine was provided via DMs (Figure 5).
Microspheres Filled with Sucrose or
Maltose Improved L. reuteri Survival at
Low pH
Orally consumed probiotics face a significant pH challenge upon
reaching the stomach, where pH values are as low as 1.5 when the
FIGURE 5 | Histamine can be produced by L. reuteri from L-histidine
delivered via DM. Stationary phase WT L. reuteri was incubated for 2 h in
either saline with and without 3% maltose or 2% glycerol, or 4 mg/ml
L-histidine with and without 3% maltose or 2% glycerol. Histamine production
was increased with addition of 3% maltose to 4 mg/ml L-histidine solution
(white bar black border) compared to just 4 mg/ml L-histidine (black bar and
gray bar black border). When L-histidine at 4 mg/ml was provided via DM the
overall levels of histamine produced were significantly lower (middle 3 bars)
compared to L-histidine provided in solution (left 4 bars), likely due to less
immediate availability of L-histidine to the bacteria. However, when the
concentration of L-histidine loaded into DM was increased to 30 mg/ml,
significantly more histamine was produced (right 3 bars) despite any caveats
related to slower access to L-histidine due to availability only via diffusion out
of DM. Error bars represent standard error of the mean. Statistical significance
is indicated by the following: *P < 0.05, **P < 0.01.
stomach is empty (Dressman et al., 1990). Enhancing the ability
to deliver a maximal number of viable L. reuteri to the colon is
crucial to its sustainability and effectiveness as a probiotic. We
thereby hypothesized that L. reuteri bound to the surface of DMs
in the form of a biofilm would increase survival upon exposure
to acid, and that DMs filled with sucrose or maltose would
result in even greater survival in a GTFW-dependent manner. As
shown in Figure 6, less than 0.1% of WT L. reuteri without DMs
survived in synthetic gastric acid after 4 h at pH 2, which resulted
in a nearly 3 log loss of viable probiotic. Addition of water-filled
DMs did not significantly alter the survival rate of WT L. reuteri
in gastric acid; however, when either DM-sucrose or DM-maltose
was delivered withWT, nearly 1 log more survived the acid stress
(Figure 6). To show that the protective effect is dependent on
the microspheres and not the cargo within the DM lumen, we
also incubated L. reuteri with the equivalent amount of diffusible
cargo without the DMs. Acid survival in the presence of cargo
only was no different than L. reuteri alone (Figure 6), which
strongly indicated the importance of the bacterial biofilm-on-DM
delivery system for the observed protective effect.
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FIGURE 6 | Gastric acid survival. WT and 1gtfW L. reuteri (107 CFU/ml)
viability after 4 h in pH 2 synthetic gastric acid in the absence or presence of
5mg of DMs that contained water, sucrose (1M), or maltose (1M) as cargo, or
10 µl of the cargo alone without DMs. Relative survival in acid was enhanced
when WT L. reuteri was adhered as a biofilm on DMs that contained sucrose
or maltose compared to equivalent volumes of the same cargo delivered
without DMs, which indicated that the biofilm phenotype contributed to better
survival during exposure to low pH. 1gtfW showed decreased resistance to
acid compared to the WT, regardless of the presence or absence of either
DMs or sugar alone. Error bars represent standard error of the mean.
Statistical significance is indicated by the following: *P < 0.05, **P < 0.01.
To investigate whether this phenotype is GTFW-dependent,
we also tested synthetic gastric acid survival using the 1gtfW
strain of L. reuteri and found that the beneficial effect of DM-
sucrose and DM-maltose was lost (Figure 6). Interestingly, the
mutant also showed deficiency in acid survival without DMs
compared to WT, which indicated that GTFW’s role in cellular
aggregation and biofilm formation (Figure S4) may contribute
significantly to survival in synthetic gastric acid.
Microspheres Promote L. reuteri
Adherence to Human Intestinal Epithelial
Cells
Next, we examined what effect the DMs, the DM luminal cargo
and the product of the gtfW gene have on the relative adherence
of L. reuteri when delivered as planktonic cells or as biofilms
on DMs to the human intestinal cell lines DLD-1 (adult human
colonic epithelial cells) and FHs 74 Int (3–4 months gestation,
small intestine epithelial cells) in vitro. As shown in Figure 7A,
after a 1 h incubation on DLD-1 cells, significantly more WT L.
reuteri (without DMs) adhered to the colonic cells compared to
1gtfW either with or without DMs, which indicated that GTFW
contributed to host cell adherence. When L. reuteri adhered to
DMs that contained sucrose or maltose were added to colonic
cells, relative adherence of WT L. reuteri to the colonic cells was
increased by 4.7-fold for DMs that contained sucrose and by
5.2-fold for DMs that contained maltose (Figure 7A). Although
FIGURE 7 | Delivery of L. reuteri adhered to DMs as a biofilm
supported increased adherence to intestinal epithelial cells. (A)
L. reuteri WT and 1gtfW adhered as a biofilm on DMs that contained either
water, sucrose (1M), or maltose (1M), or the equivalent volume of sugar alone
(without DMs), were examined for relative adherence to human colonic DLD-1
cells after incubation for 60 min. Significantly more WT adhered to DLD-1 cells
when delivered as a biofilm on the surface of DMs that contained sucrose or
maltose, compared to water-filled DMs or the equivalent volume of sugar
alone. Significantly fewer 1gtfW mutant cells adhered to DLD-1 cells,
regardless of cargo, which indicated that the GTFW protein contributes to L.
reuteri adherence. (B) Adherence of WT to fetal small intestinal FHs 74 cells
after 60 min incubation showed that providing L. reuteri adherent on the DM
surface as a biofilm with either sucrose or maltose as cargo resulted in greater
adherence to intestinal cells. Error bars represent standard error of the mean.
Statistical significance is indicated by the following: *P < 0.05, **P < 0.01, ***P
< 0.001, ****P < 0.0001.
overall fewer WT L. reuteri adhered to the FHs 74 cells than
to DLD-1 cells, delivering the bacteria with either DM-sucrose
or DM-maltose resulted in 1.8-fold (DM-sucrose) or 2.7-fold
(DM-maltose) more adhered bacteria compared to WT bacteria
without DM (Figure 7B).
To further show that DM luminal cargo of maltose and
sucrose improved relative adherence of L. reuteri to epithelial
cells in vitro, we analyzed WT and 1gtfW L. reuteri adherence
after 1 h incubation on DLD-1 cells visually, using CSLM
(Figure 8). As with the CFU data presented in Figure 7,
delivery of WT L. reuteri as a biofilm on maltose or sucrose-
loaded DMs supported greater adherence to the DLD-1 cells
than those delivered on water-loaded DMs or with no DMs,
both by visual inspection (Figure 8A) and when analyzed by
quantification of bacterial biomass using COMSTAT analysis
of CSLM images (Figure 8B). The observed adherence was
significantly diminished in the 1gtfW mutant compared to the
wild type, consistent with measured CFUs (Figure 7A).
Finally, we tested the effect of DM adhered WT L. reuteri’s
ability to bind to mucin. While cellular binding of probiotics
likely plays a role in colonization, a healthy GI tract has a mucus
layer on the apical surface of epithelial cells, of which the primary
constituent is mucin (Turner, 2009). Indeed it is believed that
healthy commensals are found primarily within this layer so it is
imperative that our formulation maintains it enhanced probiotic
effects in the presence of mucin. As mucin adherence is not
GTF-dependent, but rather controlled by specific mucin-binding
proteins (Miyoshi et al., 2006; Lukic et al., 2012), we hypothesized
that being bound to DMs would not have an effect on the ability
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FIGURE 8 | Increased adherence to DLD-1 colonic epithelial cells is observed when L. reuteri was delivered as a biofilm attached to DMs. (A) In vitro
CLSM of DLD-1 epithelial cells (blue, DAPI), L. reuteri (green, CFSE), and DMs (red, Congo Red). WT L. reuteri (top four rows) compared to 1gtfW L. reuteri (middle
four rows) and no L. reuteri (bottom row). Bacteria and DMs were pre-stained, incubated for 1 h on pre-stained DLD-1 epithelial cells, washed three times, and fixed
for CLSM analysis. (B) Comparison of bacterial biomass quantified via COMSTAT analysis of the green channel of CLSM images of WT and 1gtfW L. reuteri. WT
without DMs (n = 10) resulted in less total bacterial signal compared to either WT + DM-sucrose (n = 10) or WT + DM-maltose (n = 10). 1gtfW showed no difference
in relative number of bacteria adhered to DLD-1 cells, regardless of the presence of DMs. Error bars represent standard error of the mean. Statistical significance is
indicated by the following: *P < 0.05, **P < 0.01.
of L. reuteri to adhere to mucin. As shown in Figure S8, there is
no significant difference in relative adherence of WT L. reuteri to
mucin when delivered as either a planktonic bacterial suspension
or as a biofilm adhered to DMs after a 60 min incubation on
mucin agar plates.
DISCUSSION
We have previously shown that a single dose of L. reuteri
delivered as a biofilm adhered to DMs reduces the incidence
of necrotizing enterocolitis (NEC) by 50% (Olson et al., 2016)
in a rat pup model. Here we showed that L. reuteri bound
to DMs with appropriate luminal cargo promoted significantly
increased survival at low pH and supported increased adherence
to human epithelial cells in vitro. Importantly L. reuteri and DMs
are considered “generally recognized as safe” (GRAS) by the FDA.
In fact, DMs have been used in medical products that are left in
the body for long periods of time (years) with no ill effects (Hoy,
2012), such as with Debrisan R©, a cicatrizant wound dressing
(Jacobsson et al., 1976), Deflux R©, a bulking gel used to treat
vesicoureteral reflux (VUR) in children (Stenberg and Lackgren,
1995), and SolestaTM, a bulking gel injected submucosaly into
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the anal canal to treat fecal incontinence (Hoy, 2012). The scope
of the research presented here shows a small subset of possible
beneficial cargos that can be placed into the DM lumen for
utilization by L. reuteri, and for many applications it may be
as simple as matching the correct lumen cargo precursor to the
desired L. reuteri-produced effect (e.g., reuterin and histamine).
Moreover, this formulation obviates recombinant versions of
probiotics, an approach not currently approved by the FDA
(Venugopalan et al., 2010).
An exciting feature of our novel formulation is the ability to
directly deliver beneficial compounds to the probiotic bacteria
that are adhered to the DM surface as a biofilm (Figure 1).
To combine beneficial compounds (prebiotics) with beneficial
bacteria to stimulate growth is a well-established concept in
probiotic research and commercial applications (Collins and
Gibson, 1999; de Vrese and Schrezenmeir, 2008). There is
significant evidence to show that synergism between probiotics
and prebiotics effectively increases the overall population of
probiotic bacteria (de Vrese and Schrezenmeir, 2008; van Zanten
et al., 2014) and promotes effective treatments of diseases such as
inflammatory bowel disease (Geier et al., 2007) and necrotizing
enterocolitis (Asmerom et al., 2015). However, a major drawback
of traditional prebiotics is that they are typically limited to
carbohydrates that are non-digestible or absorbable by the host
to ensure sufficient availability to the probiotic bacteria in the
gut. Our delivery system effectively solves this problem in that the
probiotic bacterium L. reuteri is now delivered: (1) in association
with DMs to which it adheres in greater numbers; (2) in the
form of a biofilm which confers resistance to clearance; (3) along
with a cargo of nutrients that promotes bacterial growth; (4) with
cargos that promote production of the antimicrobial reuterin
or histamine; (5) in a format that is resistant to acid-mediated
killing thus promoting improved survival during transit through
the acidic stomach, and (6) in a manner that appeared to better
support adherence to intestinal epithelial cells and thus likely to
promote persistence in the gut. With regard to L. reuteri-induced
release of substance potentially beneficial to the host, reuterin
has been suggested to inhibit competition by other gut flora,
and histamine has been shown to have anti-inflammatory effects.
Although the secondary metabolites produced from glycerol
metabolism to generate reuterin (e.g., acrolein) and histamine
could result in adverse effects at high levels, the maximum
quantities generated with our formulations are <1% and <
40% less than what is thought to be problematic in humans
for acrolein (Figure S7) and histamine, respectively (Maintz and
Novak, 2007; Thomas et al., 2012; Engels et al., 2016). Ongoing
and future experiments utilizing L. reuteri adhered to DMs
will test the putative aforementioned beneficial cargos in an in
vivo animal model (Olson et al., in preparation) to demonstrate
both safety and efficacy. Concurrently we are also investigating
strategies for long-term storage and downstream application and
delivery of our DM-based formulation.
Using maltose as cargo have particular value for several
reasons; it is the substrate for this strain of L. reuteri’s
glucosyltransferase (GTFW) (Leemhuis et al., 2013; Bai et al.,
2015), induces L. reuteri to aggregate in a GTF-dependent
manner (Walter et al., 2008), and causes L. reuteri to grow
significantly faster and to a higher cell density (CFU/ml). In
this study, we show that both maltose and sucrose have a
positive effect on L. reuteri adherence to microspheres, promote
adherence of L. reuteri to human intestinal epithelial cells, and
improves bacterial survival in gastric acid (Figures 2, 3, 6, 7,
8). We have demonstrated in concurrent work that S. mutans
binds rapidly and with high affinity to DMs, and the effect
is increased in the presence of sucrose in a GTF-dependent
manner (Mashburn-Warren et al., submitted). S. mutans and L.
reuteri GTF proteins are very similar in sequence and structure.
Sucrose is the sole substrate for S. mutans and most L. reuteri
GTF proteins (Tieking et al., 2005; Walter et al., 2008), and
sucrose has previously been shown to cause L. reuteri cultures
to aggregate rapidly in a GTF-dependent manner (Walter et al.,
2008). The positive effect of sucrose to induce GTFW dependent
adhesion is likely due to GTFW acting as an adhesin to DMs
(via the glucan binding domain) and sucrose’s ability to induce
gtfW expression (Figure S3A). Indeed, failure of sucrose to affect
L. reuteri adherence to CMs (cross-linked glucan with variant
glycosidic linkages) supports this notion. Sucrose-dependent
biofilm formation has previously been linked to two-component
regulatory systems in the rodent strain 100-23 of L. reuteri (Frese
et al., 2011; Su and Ganzle, 2014); however, the genes necessary
for this phenomenon appear to be absent in the human-derived
strain of L. reuteri used in this study (23272/DSM 20016). Since
sucrose is a preferred carbon source of the L. reuteri used in this
study via its sucrose phophorylase mediated metabolism (Ganzle
and Follador, 2012) it was not surprising that sucrose had a
positive impact on biofilm formation and increased adherence to
DMs and is likely due to the increased doubling time of L. reuteri
in the presence of sucrose. The failure of glucose (a carbon source
but not a gtfW inducer or GTFW substrate) and fructose [an
inducer of gtfW, but not a carbon source (Figure S3 and data not
shown), or substrate for GTFW] to enhance adherence to DMs
suggests that understanding bacterial physiology will be critical
in selecting beneficial luminal cargos.
Although we describe L. reuteri adhered to DMs as a
biofilm, we have yet to characterize this physiologic state. We
have demonstrated in previous work with the dental pathogen
Aggregatibacter actinomycetemcomitans, that challenging a host
with an already-established pathogenic biofilm results in greater
ability of the pathogen to establish disease in an animal model of
oral infection (Freire et al., 2011, 2017).While it is clear that being
bound toDMs offersmultiple advantages in terms of survivability
and relative adherence to an epithelial target cell, the actual state
of the DM-adhered L. reuteri and its phenotype has yet to be
determined. There is evidence that microbes such as L. reuteri
exist naturally as biofilms in the gastrointestinal tract (Macfarlane
and Dillon, 2007), but there has thus far been a lack of research as
to the composition and dynamics of biofilm communities of the
gut (Hall-Stoodley et al., 2004; de Vos, 2015). L. reuteri adhered
to DMs in our experiments are biofilms by definition and via our
observations in Figure 6, which showed that bacteria adhered to
DMs resisted low pH challenge better than planktonic bacteria.
In experiments where L. reuteri bound toDMs are incubated with
colonic cells we observed both aggregates of bacteria surrounding
the DMs as well as those that were adhered to the confluent
eukaryotic cell surface (Figure S9). Future work on the biofilm
state will include the dlt operon that encodes proteins involved
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in D-alanylation of teichoic acid, and shown to be important
in biofilm formation, adherence, and host colonization (Walter
et al., 2007).
In this study we show that many parameters important
to L. reuteri’s survivability and sustainability within the host
can be improved by delivering L. reuteri as a biofilm on
the surface of DMs that contain beneficial cargo. With more
viable bacteria available after low pH challenge and supporting
increased adherence to intestinal epithelial cells, the resulting
expansion of probiotic bacteria available within the host should
have an increased potentially beneficial effect. Further, we are
able to deliver targeted nutrients and substrates directly to
the bacteria adhered on the DM surface, which has broad-
reaching implications for the type of compounds that can be
co-delivered with orally consumed L. reuteri, which to date
have been limited to carbohydrates that are indigestible by
the host. Taken together, our novel delivery system provides
an exciting framework for future probiotic development and
deployment.
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